Suppr超能文献

对糖尿病患者骨脆性的见解:骨质量对骨骼强度的关键作用。

Insights into bone fragility in diabetes: the crucial role of bone quality on skeletal strength.

作者信息

Yamamoto Masahiro

机构信息

Internal Medicine 1, Shimane University Faculty of Medicine, Izumo 693-8501, Japan.

出版信息

Endocr J. 2015;62(4):299-308. doi: 10.1507/endocrj.EJ15-0129. Epub 2015 Mar 21.

Abstract

Meta-analyses have revealed that the relative risk of hip fractures in patients with type 1 and type 2 diabetes mellitus is higher than that in non-diabetic subjects. The risk of fracture in patients with diabetes mellitus increases along with a decrease in bone mineral density (BMD) similarly to those in non-diabetic patients. However, the observed risk of fracture is higher than expected one by BMD in both type 1 and type 2 diabetic patients, indicating that precise estimation of bone fragility by BMD values in patients with diabetes is difficult. Bone strength consists of BMD and bone quality, for this reason, poor bone quality is a most suitable and explicable cause for elevated fracture risk in this population. This bone fragility observed in patients with diabetes mellitus is caused by unique pathogenesis in diabetes, suggesting that osteoporosis in diabetic patients may be one of the diabetic complications and that specific diagnostic criteria for this osteoporosis is required. Bone quality indicators closely related to bone fragility are required to be identified to establish a diagnostic method for osteoporosis in patients with diabetes mellitus.

摘要

荟萃分析表明,1型和2型糖尿病患者髋部骨折的相对风险高于非糖尿病患者。与非糖尿病患者一样,糖尿病患者的骨折风险随着骨密度(BMD)的降低而增加。然而,1型和2型糖尿病患者观察到的骨折风险均高于根据骨密度预期的风险,这表明通过骨密度值精确评估糖尿病患者的骨脆性较为困难。骨强度由骨密度和骨质量组成,因此,骨质量差是该人群骨折风险升高的最合理且可解释的原因。糖尿病患者中观察到的这种骨脆性是由糖尿病独特的发病机制引起的,这表明糖尿病患者的骨质疏松可能是糖尿病并发症之一,并且需要针对这种骨质疏松制定特定的诊断标准。需要确定与骨脆性密切相关的骨质量指标,以建立糖尿病患者骨质疏松的诊断方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验